盈利预期修正

Search documents
First Financial Bankshares (FFIN) Q2 Earnings and Revenues Top Estimates
ZACKS· 2025-07-17 22:16
Core Viewpoint - First Financial Bankshares (FFIN) reported quarterly earnings of $0.47 per share, exceeding the Zacks Consensus Estimate of $0.45 per share, and showing an increase from $0.37 per share a year ago, indicating a positive earnings surprise of +4.44% [1][2] Financial Performance - The company posted revenues of $159.53 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.52%, compared to $137.11 million in the same quarter last year [2] - Over the last four quarters, First Financial has exceeded consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance and Outlook - First Financial shares have increased by approximately 0.8% since the beginning of the year, while the S&P 500 has gained 6.5% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] Earnings Estimates - The current consensus EPS estimate for the upcoming quarter is $0.47 on revenues of $157.2 million, and for the current fiscal year, it is $1.80 on revenues of $618.8 million [7] - The estimate revisions trend for First Financial was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Banks - Southwest industry, to which First Financial belongs, is currently ranked in the top 17% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]
U.S. Bancorp (USB) Q2 Earnings Surpass Estimates
ZACKS· 2025-07-17 12:55
Core Viewpoint - U.S. Bancorp reported quarterly earnings of $1.11 per share, exceeding the Zacks Consensus Estimate of $1.07 per share, and showing an increase from $0.98 per share a year ago, indicating a positive earnings surprise of +3.74% [1][2] Financial Performance - The company posted revenues of $7 billion for the quarter ended June 2025, which was 0.84% below the Zacks Consensus Estimate, compared to $6.84 billion in the same quarter last year [2] - Over the last four quarters, U.S. Bancorp has surpassed consensus EPS estimates four times but has only topped revenue estimates once [2] Stock Performance - U.S. Bancorp shares have declined approximately 4.5% year-to-date, contrasting with the S&P 500's gain of 6.5% [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it is expected to perform in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.08 on revenues of $7.17 billion, and for the current fiscal year, it is $4.30 on revenues of $28.41 billion [7] - The trend of earnings estimate revisions is mixed ahead of the earnings release, which may influence future stock performance [6] Industry Context - The Banks - Major Regional industry, to which U.S. Bancorp belongs, is currently ranked in the top 6% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact investor sentiment [5]
Does Rapt Therapeutics (RAPT) Have the Potential to Rally 183.83% as Wall Street Analysts Expect?
ZACKS· 2025-07-15 14:56
Core Viewpoint - Rapt Therapeutics (RAPT) shares have increased by 5.8% recently, closing at $8.72, with a mean price target of $24.75 suggesting a potential upside of 183.8% [1][2] Price Targets and Analyst Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $17.35, indicating variability among analysts [2] - The lowest estimate is $8.00, suggesting an 8.3% decline, while the highest estimate is $48.00, indicating a potential surge of 450.5% [2] - A low standard deviation indicates a strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Agreement - Analysts have shown increasing optimism about RAPT's earnings prospects, with a positive trend in earnings estimate revisions [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 24.1%, with one estimate moving higher and no negative revisions [12] - RAPT holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be wise, as analysts' ability to set accurate targets has been questioned [3][10] - Price targets can often be inflated due to business incentives, leading to overly optimistic projections [8]
Does Harmony Biosciences (HRMY) Have the Potential to Rally 43.19% as Wall Street Analysts Expect?
ZACKS· 2025-07-15 14:56
Group 1 - Harmony Biosciences Holdings, Inc. (HRMY) shares have increased by 5.5% over the past four weeks, closing at $34.71, with a mean price target of $49.7 indicating a potential upside of 43.2% [1] - The mean estimate consists of 10 short-term price targets with a standard deviation of $11.66, where the lowest estimate is $31.00 (10.7% decline) and the highest is $70.00 (101.7% increase) [2] - Analysts show a consensus that HRMY will report better earnings than previously estimated, which is a positive indicator for potential stock upside [4][11] Group 2 - The Zacks Consensus Estimate for HRMY has increased by 0.2% due to one upward revision in earnings estimates over the last 30 days, with no negative revisions [12] - HRMY holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for near-term upside [13] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [14]
United (UAL) Moves 14.3% Higher: Will This Strength Last?
ZACKS· 2025-07-11 16:06
Group 1: United Airlines (UAL) - United Airlines shares increased by 14.3% to close at $91.67, driven by higher trading volume compared to typical sessions [1] - The stock's performance contrasts with a 2% gain over the past four weeks [1] - The consensus EPS estimate for United has been revised 5.4% lower in the last 30 days, indicating a negative trend in earnings estimate revisions [4] Group 2: Airline Industry - Optimism in the airline industry was fueled by Delta Air Lines' better-than-expected Q2 2025 earnings results, which included earnings and revenue beats and the restoration of full-year guidance [2] - Delta Air Lines is expected to report quarterly earnings of $3.75 per share, reflecting a year-over-year decline of 9.4%, with revenues projected at $15.31 billion, a 2.2% increase from the previous year [2] - Corporacion America Airports, another airline stock, has seen a consensus EPS estimate change of -1.9% to $0.47, but this represents a significant year-over-year increase of 51.6% [6]
CSW Industrials (CSW) Stock Jumps 3.6%: Will It Continue to Soar?
ZACKS· 2025-07-11 09:31
Group 1: Company Performance - CSW Industrials (CSW) shares increased by 3.6% to close at $304.67, supported by higher trading volume compared to normal sessions, despite a 3.6% loss over the past four weeks [1] - The company is expected to report quarterly earnings of $2.74 per share, reflecting a year-over-year increase of 10.9%, with revenues projected at $276.99 million, up 22.5% from the previous year [3] - The consensus EPS estimate for CSW has been revised 1.7% lower in the last 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [4] Group 2: Growth Drivers - Optimism regarding strong growth in the Contractor Solutions segment and recent strategic acquisitions, including Dust Free, PSP Products, and PF WaterWorks, is contributing to revenue growth [2] - The HVAC/R and electrical end markets are also playing a significant role in supporting the company's growth [2] Group 3: Industry Context - CSW Industrials is classified under the Zacks Chemical - Specialty industry, where it holds a Zacks Rank of 2 (Buy) [5] - Another company in the same industry, Blachem (BCPC), experienced a 0.4% decline, with a return of -1.5% over the past month, and has a Zacks Rank of 3 (Hold) [5][6]
Helen of Troy (HELE) Q1 Earnings and Revenues Miss Estimates
ZACKS· 2025-07-10 12:56
Company Performance - Helen of Troy (HELE) reported quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.91 per share, and down from $0.99 per share a year ago, representing an earnings surprise of -54.95% [1] - The company posted revenues of $371.66 million for the quarter ended May 2025, missing the Zacks Consensus Estimate by 6.93%, and down from $416.85 million year-over-year [2] - Over the last four quarters, Helen of Troy has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Helen of Troy shares have lost about 48.2% since the beginning of the year, while the S&P 500 has gained 6.5% [3] - The current Zacks Rank for Helen of Troy is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the coming quarter is $1.07 on revenues of $458.04 million, and for the current fiscal year, it is $5.04 on revenues of $1.84 billion [7] - The outlook for the cosmetics industry, where Helen of Troy operates, is currently in the top 4% of over 250 Zacks industries, suggesting a favorable environment for performance [8]
Saratoga Investment (SAR) Q1 Earnings and Revenues Lag Estimates
ZACKS· 2025-07-08 22:16
Earnings Performance - Saratoga Investment reported quarterly earnings of $0.66 per share, missing the Zacks Consensus Estimate of $0.69 per share, and down from $1.05 per share a year ago, representing an earnings surprise of -4.35% [1] - The company posted revenues of $32.32 million for the quarter ended May 2025, missing the Zacks Consensus Estimate by 1.36%, and down from $38.68 million year-over-year [2] Market Performance - Saratoga Investment shares have increased approximately 6.4% since the beginning of the year, outperforming the S&P 500's gain of 5.9% [3] Future Outlook - The current consensus EPS estimate for the coming quarter is $0.73 on revenues of $33.12 million, and for the current fiscal year, it is $2.84 on revenues of $133.6 million [7] - The Zacks Industry Rank indicates that the Financial - SBIC & Commercial Industry is currently in the bottom 5% of over 250 Zacks industries, which may impact stock performance [8] Estimate Revisions - The estimate revisions trend for Saratoga Investment was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6]
Strength Seen in SharkNinja, Inc. (SN): Can Its 7.2% Jump Turn into More Strength?
ZACKS· 2025-07-03 13:51
Company Overview - SharkNinja, Inc. (SN) shares increased by 7.2% to close at $106.36, with notable trading volume compared to typical sessions, and a total gain of 7.5% over the past four weeks [1] - The company is implementing a three-pillar strategy focused on innovation, category expansion, and global growth to gain market share [2] Financial Performance - SharkNinja is expected to report quarterly earnings of $0.78 per share, reflecting a year-over-year increase of 9.9%, with revenues projected at $1.37 billion, up 9.3% from the previous year [2] - The consensus EPS estimate for SharkNinja has been revised 1.1% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [4] Market Position - SharkNinja holds a Zacks Rank of 1 (Strong Buy), suggesting strong market confidence in the stock [4] - In the same industry, Arhaus, Inc. (ARHS) saw a 3.5% increase in its stock price, but it has a lower Zacks Rank of 3 (Hold) [4][5]
大摩:本轮美股上涨有坚实的基本面
Hua Er Jie Jian Wen· 2025-07-01 02:58
Group 1 - The core viewpoint of the article is that the recent rebound in the US stock market is supported by fundamental improvements, driven by three key factors: earnings expectations revision, a shift in Federal Reserve policy expectations, and a reduction in geopolitical and policy risks [1][10][12] Group 2 - Earnings expectations have significantly improved, with the breadth of earnings revisions rising from a low of -25% in mid-April to -5%, indicating a strong recovery in corporate earnings outlook [3][5] - Historical data suggests that similar V-shaped recoveries in earnings revisions often lead to strong market returns over the following 12 months [5] - The preference for large-cap quality stocks, represented by the "Magnificent Seven," continues to lead in earnings revisions and stock performance, while small-cap stocks lag behind historical highs [7][14] Group 3 - The market is increasingly pricing in potential interest rate cuts by the Federal Reserve, with Morgan Stanley predicting up to seven rate cuts by the end of next year, which could support stock valuations in the second half of this year [10][11] - Employment market data will be a key trigger for the Fed's policy shift, with significant private sector job growth below expectations potentially prompting earlier rate cuts [11] Group 4 - Geopolitical risks have eased, with oil prices dropping 14% since June 19, reducing inflationary pressures and potential threats to the business cycle [13] - The removal of concerns regarding the "capital tax" clause from the "Big Beautiful" plan alleviates risks related to foreign direct investment in the US [13] Group 5 - The current stock risk premium is at a 20-year low, while earnings risk is at a 20-year high, indicating a notable contradiction that warrants attention [14] - Long-term prospects remain optimistic, with AI-driven productivity improvements expected to contribute an additional 30 basis points to S&P 500 net profit margins by 2025-2026, expanding to 50 basis points by 2027 [16]